Axon Shares Sink 18% Despite Record Sales as $130 Million in Federal Drone Work Slips

Axon Enterprise delivered record quarterly sales and faster growth in its software business, but its stock finished sharply lower on Friday, November 6, 2026. TickerCanvas's cached end-of-day adjusted-close data for the November 6 session show shares of the S&P 500 constituent (NASDAQ: AXON) at $313.00, down 18.18% versus the preceding trading session. This is a dated closing-session measure, not a live quote. The broader S&P 500 gained about 0.3% that day. The contrast followed a November 5 earnings release in which Axon reduced its full-year sales outlook.

Record revenue, but a lower full-year target

Third-quarter revenue reached approximately $908.6 million, up 28% year over year, Axon reported. Software & Services sales rose 43% to $437 million, while annual recurring revenue, an operating run-rate measure rather than booked quarterly revenue, increased 40% to $1.75 billion. GAAP net income was about $57 million, compared with a $2.2 million net loss a year earlier.

Those gains did not prevent an outlook reduction. Axon now expects 2026 revenue of roughly $3.61 billion to $3.63 billion, equivalent to approximately 30% annual growth, compared with its earlier forecast of 32% to 34% growth.

The $130 million issue is timing, not confirmed cancellation

Axon attributed the weaker annual revenue outlook to three large federal deployments associated with its Dedrone counter-drone business. Together, they represent approximately $130 million of revenue that the company no longer expects to recognize in 2026. Management said the deployments had been included in its previous expectations.

This is an important distinction: the company identified a change in the timing of expected revenue, not a confirmed cancellation of all three projects. It has not established in this announcement precisely when that revenue will instead be recorded. Investors therefore face a question about execution and recognition timing, not just the underlying demand for public-safety technology.

Axon also lowered its full-year free-cash-flow outlook to $350 million–$400 million from a previous $450 million target. It linked that revision to accelerated inventory investment aimed at improving product availability and supply-chain resilience, rather than describing it as a direct effect of the Dedrone delays.

A bigger drone strategy adds another moving part

In the same announcement, Axon disclosed agreements for up to $1.2 billion of additional investment in drone maker Skydio, intended to increase its fully diluted ownership from 15% to approximately 37% once the transactions close. Its SEC filing states that an initial investment of approximately $254.9 million closed on November 5, while remaining transactions valued at up to approximately $968.6 million are expected to close during Q4 2026 and Q1 2027, subject to customary conditions. Axon also announced an exclusive public-safety distribution relationship with Skydio in the United States and Canada. This is distinct from the delayed federal Dedrone deployments; the commercial results and financial effects of the expanded arrangement remain uncertain.

Meanwhile, the company's consolidated GAAP gross margin fell to 56.7% from 60.1% a year earlier. Axon cited product mix, including counter-drone equipment, and higher memory costs within its Connected Devices business. This matters because rapid top-line expansion does not necessarily translate into equally rapid margin or cash-flow growth.

Why it matters for the S&P 500

Axon joined the S&P 500 in May 2023 and remains in the index's current constituent universe. Its November 6 decline illustrates how an index member can report strong historical growth while repricing sharply when management changes the path of near-term expected revenue. The share-price move followed multiple disclosed developments; it cannot be attributed to any one disclosure with certainty.

The next evidence to watch is whether the federal deployments progress toward recognition, how quickly software subscriptions continue expanding, and whether inventory spending and hardware margins stabilize. None of those outcomes is assured by the existing bookings or management projections.

TickerCanvas Editorial